References
- FordHLGerryEJohnsonMWilliamsRA prospective study of the incidence, prevalence and mortality of multiple sclerosis in LeedsJ Neurol200224926026511993523
- SlokaJSPryse-PhillipsWEStefanelliMIncidence and prevalence of multiple sclerosis in Newfoundland and LabradorCan J Neurol Sci200532374215825544
- IngleseMMultiple sclerosis: New insights and trendsAm J Neuroradiol20062795495716687523
- Al-SabbaghABennetRKozmaCDicksonMMeleticheDMedication gaps in disease-modifying therapy for multiple sclerosis are associated with an increased risk of relapse: Findings from a national managed care databaseJ Neurol.2008255Suppl 2S79
- CostelloKKennedyPScanzilloJRecognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long termMedscape J Med20081022519008986
- DevonshireVLapierreYMacdonellRThe Global Adherence Project (GAP): A multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosisEur J Neurol2010614 [Epub ahead of print]
- TreadawayKCutterGSalterAFactors that influence adherence with disease-modifying therapy in MSJ Neurol200925656857619444532
- LugaresiAAddressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivationExpert Opin Drug Deliv20096995100219637982
- BrochetBLemaireGBeddiafAReduction of injection site reactions in multiple sclerosis (MS) patients newly started on interferon beta 1b therapy with two different devicesRev Neurol (Paris)2006162735740 French.16840982
- LugaresiADurastantiVGasperiniCSafety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: The CoSa studyClin Neuropharmacol20083116717218520983
- MikolDLopez-BresnahanMTaraskiewiczSChangPRangnowJA randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosisMult Scler20051158559116193898
- BayasAJappGFuldaUKallmannBInjection devices in the basic therapy of multiple sclerosis. Survey among neurologists, MS nurses and patientsNervenheilkunde2010295762 [German].
- DevonshireVArbizuTBorreBPatient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: An international, single-arm, multicentre, Phase IIIb studyBMC Neurol2010102820433746
- ExellSVerdunEDriebergenRMigliaccioMDevelopment of an electronic injection device for subcutaneous interferon beta-1a administration in patients with relapsing multiple sclerosisJ Neurol Sci.2009285SupplS203
- DiglasJFeinbockCIrsiglerKReduced pain perception with Pen Mate™, an automatic needle insertion device for use with an insulin penPractical Diabetes1999163941